Erickson Michael G 4

Accession 0000874716-25-000022

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:42 PM ET

Size

27.6 KB

Accession

0000874716-25-000022

Form 4

Period: 2025-02-13

Executive Vice President

Transactions

Exercise/Conversion
Restricted Stock Unit
2025-02-14−69→ 0 total
→ Common Stock (69 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−93→ 92 total
→ Common Stock (93 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−94→ 188 total
→ Common Stock (94 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−301→ 903 total
→ Common Stock (301 underlying)
Exercise/Conversion
Common Stock
2025-02-14+69→ 20,905.362 total
Exercise/Conversion
Common Stock
2025-02-14+93→ 20,998.362 total
Exercise/Conversion
Common Stock
2025-02-14+94→ 21,092.362 total
Exercise/Conversion
Common Stock
2025-02-14+301→ 21,393.362 total
Tax Payment
Common Stock
2025-02-14$444.53/sh−177$78,682→ 21,216.362 total
Award
Non-Qualified Stock Option (right-to-buy)
2025-02-13+6,320→ 6,320 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (6,320 underlying)
Award
Incentive Stock Option (right-to-buy)
2025-02-13+217→ 217 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (217 underlying)
Award
Restricted Stock Unit
2025-02-13+734→ 734 total
→ Common Stock (734 underlying)
Award
Restricted Stock Unit
2025-02-13+734→ 734 total
→ Common Stock (734 underlying)

Footnotes (8)

[F1]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
[F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
[F3]Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
[F4]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
[F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2022.
[F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
[F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2024.
[F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2025.

Documents

1 file

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother